Exact Mass: 413.0446

Exact Mass Matches: 413.0446

Found 14 metabolites which its exact mass value is equals to given mass value 413.0446, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Desacetylcefotaxime

(6R,7R)-7-{[(2Z)-1-hydroxy-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H15N5O6S2 (413.0464)


Desacetylcefotaxime belongs to the family of Cephems. These are organic compounds containing the 5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one nucleus[1]. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide

N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulphonamide

C17H14ClF2N3O3S (413.0412)


PLX-4720 is a potent and selective inhibitor of?B-RafV600E?with?IC50?of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), and 10-fold selectivity for B-RafV600E than wild-type B-Raf.

   

ZINC3161614

ZINC3161614

C17H17Cl2N3O3S (413.0368)


   

25I-NBOH

25I-NBOH

C17H20INO3 (413.0488)


   

Desacetylcefotaxime

3-Desacetyl Cefotaxime

C14H15N5O6S2 (413.0464)


   

Cefdaloxime

Cefdaloxime

C14H15N5O6S2 (413.0464)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

5-[(3,4-dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

5-[(3,4-dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

C19H13Cl2N5O2 (413.0446)


   

N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-nitrobenzamide

N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-nitrobenzamide

C19H16BrN3O3 (413.0375)


   

Cefdinir monohydrate

Cefdinir monohydrate

C14H15N5O6S2 (413.0464)


   

2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide

2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide

C16H16ClN3O6S (413.0448)


   

5-(4-Bromophenyl)-4-(4-hydroxy-3-methoxyphenyl)-3-methyl-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one

5-(4-Bromophenyl)-4-(4-hydroxy-3-methoxyphenyl)-3-methyl-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one

C19H16BrN3O3 (413.0375)


   

(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H15N5O6S2 (413.0464)


   

PLX-4720

N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide

C17H14ClF2N3O3S (413.0412)


PLX-4720 is a potent and selective inhibitor of?B-RafV600E?with?IC50?of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), and 10-fold selectivity for B-RafV600E than wild-type B-Raf.

   

(e)-[(2e,4z,6e)-4,8-dichloro-3,7-dimethylocta-2,4,6-trien-1-ylidene][(2,3,4,5,6-pentafluorophenyl)methoxy]amine

(e)-[(2e,4z,6e)-4,8-dichloro-3,7-dimethylocta-2,4,6-trien-1-ylidene][(2,3,4,5,6-pentafluorophenyl)methoxy]amine

C17H14Cl2F5NO (413.0373)